Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Apeiron and Rentschler Announces Partnership Agreement
Friday, August 02, 2013
Rentschler produces Apeiron's monoclonal antibody APN311 for late stage clinical development and market.

Thermo Fisher Scientific Showcases New Small Benchtop Centrifuge at AACC
Thursday, August 01, 2013
Provides scientists with outstanding capacity in a compact design.

Intelsius Introduces Reusable Courier Transit Case
Monday, July 29, 2013
BioCarrier™ - Designed for local courier routes and multiple site sample collections.

BASF, Cargill and Novozymes Achieve Milestone in Bio-Based Acrylic Acid Process
Thursday, July 11, 2013
Success in producing 3-hydroxypropionic acid for bio-based acrylic acid.

Ask the Expert: Strategies to Maximize Return on Idle Equipment
Monday, June 24, 2013
Roger Gallo answers some frequently asked questions about how to achieve a good return on equipment.

Reaction Biology Top-Ranked in Kinase Profiling Survey
Wednesday, June 19, 2013
RBC also ranked highly on technical support and data quality.

Cobra Biologics and Novolytics Unveil Successful Development of Bacteriophages Against Bacterial Infection
Wednesday, June 12, 2013
Cobra to present its methodology, approach, and acquired expertise in phage manufacture at the Phages 2013.

Novel Saltwater Treatment Device
Monday, May 27, 2013
Cambridge Consultants develops innovative nebulizer to treat cystic fibrosis.

Novozymes Biopharma’s Recombinant Human Albumin Helps Dry Eye Therapy Move into Clinical Trials
Wednesday, May 22, 2013
A novel ophthalmic solution from R-Tech Ueno (Tokyo, Japan) made using Novozymes Biopharma’s recombinant human albumin has recently obtained FDA approval to undergo Phase I/II clinical trials in the United States.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 294
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv